# Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease

> **NCT06370039** · PHASE2 · COMPLETED · sponsor: **Invirsa, Inc.** · enrollment: 109 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** INV-102
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT06370039
- **Lead sponsor:** Invirsa, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-27
- **Primary completion:** 2024-07-03
- **Final completion:** 2024-07-03
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06370039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06370039, "Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT06370039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*